Abstract: The role of commercially available Ammonium chloride in organic synthesis can not be understated. This review summarizes the versatile synthetic applications of Ammonium chloride in different chemical transformations. Reactions include Claisen rearrangement, Ullmann coupling, thia-Michael addition, three-component synthesis of dihydropyrimidinones, imidazo[1,2-a]pyridines, tetrahydrobenzo[a]xanthene-11-ones, benzoxazines, iminooxazolines, imidazo[1,2-a]pyrimidines, spirochromenes, spiroacridines, four-component synthesis of dipeptides, pyrrolo[3,4-b]pyridine-5-ones, crossed-aldol condensation, condensation of carbonyl compounds and indoles, synthesis of quinoxalines, arylbenzothiazoles, bisbenzothiazoles, reduction, and oxidation. Application of this catalyst allows mild and highly selective transformation and synthesis in a facile and environmentally friendly manner. Moreover, Ammonium chloride is an inexpensive and easily available catalyst, which acts under neutral conditons.
Keywords: Ammonium Chloride, Inexpensive, Environmentally Friendly, Acid Catalysis, Organic Synthesis
[1]. (a) Phillips, W. A.; Hosking, C. S.; Shelton, M. J.; J. Clin. Pathol. 1983, 36, 808. (b) Shamsuri, A. A.; Abdullah, D. K. International
J. Chem. 2011, 3, 161. (c) Karuvalam, R. P.; Divia, S. M.; Haridas, K. R. J. Korean Chem. Soc. 2010, 54, 589. (d) Xu, L.-W.; Li, J.-
W.; Zhou, S.-L.; Xia, C.-G. New J. Chem. 2004, 28, 183. (e) Hawley, G. G. The Sigma Algrich Library of Chemical Safety Data,
Edition II, 2005.
[2]. Rallis, J. W.; Lundin, R. E.; Bailey, G. F. J. Org. Chem. 1963, 28, 3521.
[3]. Li, J.-H.; Liang, Y.; Liu, W.-J.; Tang, S.; Xie, Y.-X. Chin. J. Chem. 2004, 22, 1432.
[4]. Chen, W.-Y.; Shi, L. Catal. Commun. 2008, 9, 1079.
[5]. Kappe, C. O. Tetrahedron 1993, 49, 6937.
[6]. (a) Gueiffier, A; Lhassani, M.; Elhakmaoui, A.; Snoeck, R.; Andrei, G.; Chavignon, O.; Teulade, J. C.; Kerbal, A.; Essassi, E. M.;
Debouzy, J. C.; Witvrouw, M.; Blache, Y.; Balzarini, J.; De Clercq, E.; Chapat, J. P. J. Med. Chem. 1996, 39, 2856. (b). Gueiffier, A;
Mavel, S.; Lhassani, M.; Elhakmaoui, A.; Snoeck, R.; Andrei, G.; Chavignon, O.; Teulade, J. C.; Witvrouw, M.; Balzarini, J.; De
Clercq, E.; Chapat, J. P. J. Med. Chem. 1998, 41, 5108. (c) Mavel, S.; Renou, J. L.; Galtier, C.; Snoeck, R.; Andrei, G.; Balzarini, J.;
De Clercq, E.; Gueiffier, A; Arzneim Forsch 2001, 51, 304. (d) Abignente, E. Actual Chim. Ther. 1991, 18, 193. (e) Abignente, E.;
Arena, F.; Lurachi, E.; Saturnino, C.; Rossi, F.; Lampa, E.; Cazzola, M.; Brandinelli, E.; Marrazzo, R.; Marmo, E. Rend. Atti. Accad.
Sci. Med. Chir. 1985, 139, 313. (f) Almirante, L.; Polo, L.; Mugnaini, A.; Provinciali, E.; Rugarli, P.; Biancotti, A.; Gamba, A.;
Murmann, W. J. Med. Chem. 1965, 8, 305.
[7]. (a) Poupelin, J. P.; Ruf, G. S.; Blanpin, O. F.; Narcisse, G.; Ernouf, G. U.; Lacroix, R. Eur. J. Med. Chem. 1978, 13, 67. (b) Ion, R.
M.; Planner, A.; Wiktorowicz, K.; Frackowiak, D. Acta Biochim. Pol. 1998, 45, 833.
[8]. (a) Molina, P.; Alajarin, M.; Vidal, A.; Foces-Foces, M.; Cano, F. H. Tetrahedron 1989, 45, 4263. (b) Selby, T. P.; Birch, L. D. WO
Patent 03/032731 A1, 2003; Chem. Abstr. 2003, 138: 316207. (c) Middleton, W. J.; Krespan, C. G. J. Org. Chem. 1968, 3625. (d)
Koksch, B.; Mutze, K.; Osipov, S. N.; Golubev, A. S.; Burger, K. Tetrahedron Lett. 2000, 41, 3825.
[9]. (a) Rival, Y.; Grassy, G.; Michel, G. Chem. Pharm. Bull. 1992, 40, 1170. (b) Rival, Y.; Taudou, A.; Ecalle, R. Farmaco 1993, 48,
857.
[10]. (a) Skommer, J.; Wlodkowic, D.; Matto, M.; Eray, M.; Pelkonen, J. Leuk. Res. 2006, 30, 322. (b) Andreani, L. L.; Lapi, E. Boll.
Chim. Farm. 1960, 99, 583. (c) Bonsignore, L.; Loy, G.; Secci, D.; Calignano, A. Eur. J. Med. Chem. 1993, 28, 517.